Rock Springs Capital Management LP
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
99 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,692,833,901 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| HTFL | Heartflow, Inc. | +294,800 | 572,500 | $13,928,925 | |
| ERAS | Erasca, Inc. | +151,759 | 1,103,469 | $17,854,128 | |
| BSX | Boston Scientific Corp | +116,250 | 515,300 | $32,335,075 | |
| PTCT | Ptc Therapeutics, Inc. | +99,919 | 161,798 | $11,023,297 | |
| FOCL | Edap Tms SA | +91,500 | 1,378,000 | $5,126,160 | |
| OLMA | Olema Pharmaceuticals, Inc. | +72,138 | 170,378 | $2,540,335 | |
| BCAX | Bicara Therapeutics Inc. | +60,000 | 489,095 | $9,728,099 | |
| DYN | Dyne Therapeutics, Inc. | +59,243 | 972,198 | $17,625,949 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +49,000 | 811,294 | $74,947,339 | |
| ATEC | Alphatec Holdings, Inc. | +47,500 | 350,000 | $3,808,000 | |
| ALKS | Alkermes plc. | +44,758 | 183,986 | $6,505,744 | |
| OCUL | Ocular Therapeutix, Inc | +37,896 | 383,716 | $3,250,074 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +31,381 | 170,999 | $89,512,846 | |
| ELVN | Enliven Therapeutics, Inc. | +28,095 | 826,500 | $32,398,800 | |
| CNTA | Centessa Pharmaceuticals plc | +27,813 | 351,828 | $13,974,608 | |
| IRTC | iRhythm Holdings, Inc. | +26,750 | 261,750 | $30,891,735 | |
| NBIX | Neurocrine Biosciences Inc | +24,950 | 150,450 | $19,820,283 | |
| BBIO | BridgeBio Pharma, Inc. | +24,750 | 128,250 | $9,523,845 | |
| PHVS | Pharvaris N.V. | +22,131 | 645,533 | $18,236,307 | |
| ACRS | Aclaris Therapeutics, Inc. | +18,909 | 4,472,650 | $16,772,437 | |
| PCVX | Vaxcyte, Inc. | +13,250 | 60,250 | $3,501,127 | |
| APLS | Apellis Pharmaceuticals, Inc. | +12,250 | 162,750 | $6,547,432 | |
| UNH | Unitedhealth Group Inc | +12,200 | 53,000 | $14,341,270 | |
| MLYS | Mineralys Therapeutics, Inc. | +12,155 | 439,751 | $11,912,854 | |
| SLNO | Soleno Therapeutics Inc | +10,200 | 257,253 | $8,612,830 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AGL | agilon health, inc. | −6,240,000 | 260,000 | $2,056,600 | |
| FOLD | AMICUS THERAPEUTICS, INC. | −1,908,869 | 21,062 | $304,556 | |
| GOSS | Gossamer Bio, Inc. | −1,657,468 | 1,609,492 | $529,522 | |
| TVTX | Travere Therapeutics, Inc. | −732,368 | 1,477,954 | $43,910,013 | |
| CMPX | Compass Therapeutics, Inc. | −621,894 | 3,305,308 | $17,485,079 | |
| PHR | Phreesia, Inc. | −276,200 | 600,400 | $5,031,352 | |
| COGT | Cogent Biosciences, Inc. | −224,875 | 624,155 | $24,023,725 | |
| OMDA | Omada Health, Inc. | −199,000 | 541,000 | $6,800,370 | |
| RVMD | Revolution Medicines, Inc. | −125,805 | 1,209,465 | $117,620,471 | |
| CAI | Caris Life Sciences, Inc. | −124,500 | 563,000 | $10,066,440 | |
| GPCR | Structure Therapeutics Inc. | −108,019 | 640,217 | $30,858,459 | |
| SGRY | Surgery Partners, Inc. | −102,000 | 208,000 | $2,479,360 | |
| VERA | Vera Therapeutics, Inc. | −64,994 | 503,585 | $20,259,224 | |
| EW | Edwards Lifesciences Corp | −53,600 | 28,900 | $2,314,312 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −48,468 | 1,218,773 | $25,533,294 | |
| ACHC | Acadia Healthcare Company, Inc. | −44,500 | 75,500 | $1,765,945 | |
| CLDX | Celldex Therapeutics, Inc. | −42,268 | 650,270 | $20,626,564 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −35,165 | 225,179 | $15,796,306 | |
| XENE | Xenon Pharmaceuticals Inc. | −24,768 | 763,020 | $44,369,613 | |
| ASND | Ascendis Pharma A/S | −9,500 | 194,000 | $44,373,620 | |
| LLY | ELI LILLY & Co | −6,700 | 98,700 | $90,781,299 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −5,262 | 689,748 | $59,987,383 | |
| INSM | INSMED Inc | −4,950 | 314,300 | $51,394,336 | |
| ARGX | Argenx SE | −4,750 | 98,500 | $71,929,625 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | 1,055,000 | $15,740,600 | |
| INDV | Indivior Pharmaceuticals, Inc. | 200,000 | $6,096,000 | |
| SYK | Stryker Corp | 14,800 | $4,863,132 | |
| NVO | Novo Nordisk A S | 90,000 | $3,307,500 | |
| VKTX | Viking Therapeutics, Inc. | 96,000 | $3,123,840 | |
| IPSC | Century Therapeutics, Inc. | 1,304,347 | $2,947,824 | |
| CVS | CVS HEALTH Corp | 40,000 | $2,872,800 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 26,757 | $2,245,447 | |
| ORKA | Oruka Therapeutics, Inc. | 4,123 | $202,233 | |
| BCRX | Biocryst Pharmaceuticals Inc | 12,600 | $119,952 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,209,465 | $117,620,471 | 6.95% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 98,700 | $90,781,299 | 5.36% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 170,999 | $89,512,846 | 5.29% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 811,294 | $74,947,339 | 4.43% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 98,500 | $71,929,625 | 4.25% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 689,748 | $59,987,383 | 3.54% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 314,300 | $51,394,336 | 3.04% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 194,000 | $44,373,620 | 2.62% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 763,020 | $44,369,613 | 2.62% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 1,477,954 | $43,910,013 | 2.59% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 496,871 | $41,384,385 | 2.44% | |
| PEN |
Penumbra Inc
Healthcare
|
Held | 120,500 | $39,568,585 | 2.34% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Held | 82,000 | $37,801,180 | 2.23% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 739,816 | $36,369,354 | 2.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 826,500 | $32,398,800 | 1.91% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 515,300 | $32,335,075 | 1.91% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 261,750 | $30,891,735 | 1.82% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 640,217 | $30,858,459 | 1.82% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Held | 799,163 | $27,035,684 | 1.60% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 1,218,773 | $25,533,294 | 1.51% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 74,000 | $24,484,380 | 1.45% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 624,155 | $24,023,725 | 1.42% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Held | 125,000 | $23,588,750 | 1.39% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 355,600 | $22,331,680 | 1.32% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 650,270 | $20,626,564 | 1.22% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 503,585 | $20,259,224 | 1.20% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 150,450 | $19,820,283 | 1.17% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 169,859 | $19,503,210 | 1.15% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 588,794 | $18,847,295 | 1.11% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 645,533 | $18,236,307 | 1.08% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,103,469 | $17,854,128 | 1.05% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 972,198 | $17,625,949 | 1.04% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 3,305,308 | $17,485,079 | 1.03% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Added | 4,472,650 | $16,772,437 | 0.99% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 225,179 | $15,796,306 | 0.93% | |
| MMED |
MiniMed Group, Inc.
Healthcare
|
NEW | 1,055,000 | $15,740,600 | 0.93% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 814,707 | $15,324,638 | 0.91% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 53,000 | $14,341,270 | 0.85% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 351,828 | $13,974,608 | 0.83% | |
| HTFL |
Heartflow, Inc.
Healthcare
|
Added | 572,500 | $13,928,925 | 0.82% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Held | 2,299,473 | $13,773,843 | 0.81% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
Held | 710,000 | $13,461,600 | 0.80% | |
| AZTA |
Azenta, Inc.
Healthcare
|
Held | 569,100 | $12,025,083 | 0.71% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 439,751 | $11,912,854 | 0.70% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Held | 61,500 | $11,660,400 | 0.69% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 161,798 | $11,023,297 | 0.65% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Reduced | 563,000 | $10,066,440 | 0.59% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 502,077 | $9,815,605 | 0.58% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 489,095 | $9,728,099 | 0.57% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 128,250 | $9,523,845 | 0.56% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.